# BENEPALI™ (etanercept)
Keywords: BENEPALI, etanercept, immunology, biosimilars, adverse events, healthcare professionals, treatment, injection, pen demonstration, rheumatoid arthritis, anti-TNF

> This page provides information about BENEPALI™, a biosimilar product containing etanercept, intended for healthcare professionals in the UK and Ireland. It includes resources for patient discussions, demonstration videos, and related medical materials.

## Details
- [Overview](#): General information about BENEPALI™, its use in immunology, and its role in the treatment portfolio.
- [Patient Profiles](#): Materials and resources to assist healthcare professionals in discussing BENEPALI™ with eligible patients.
- [Resources](#): Access to a range of support materials for healthcare professionals and patients.
- [BENEPALI™ Pen Demonstration Video](#): A video demonstrating the proper use of the BENEPALI™ pen for injections.
- [BENEPALI™ Syringe Injection Video](#): A video showcasing the correct method for administering BENEPALI™ using a syringe.
- [Experience with Subcutaneous Anti-TNF Biosimilars](#): A podcast featuring insights from medical professionals on the use of subcutaneous anti-TNF biosimilars.
- [Optimising Therapy in RA Patients](#): A webinar discussing strategies for managing rheumatoid arthritis patients who have not responded to their first biologic therapy.
- [FLIXABI™ (infliximab)](#): Information about another biosimilar product, FLIXABI™, and its applications.
- [IMRALDI™ (adalimumab)](#): Details about IMRALDI™, a biosimilar product, and its therapeutic uses.
- [Adverse Event Reporting](#): Information on how to report adverse events in the UK and Ireland, including contact details for Biogen.